News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Patel Sanjiv
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 1,662 shares
@ $10.68, valued at
$17.8k
|
|
| 02/09/2023 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 14,000 shares
@ $21.45, valued at
$300.3k
Sold 14,000 shares
@ $20.98, valued at
$293.7k
Sold 14,000 shares
@ $20.55, valued at
$287.7k
Exercised 14,000 options to buy
@ $5.04, valued at
$70.6k
Exercised 14,000 options to buy
@ $5.04, valued at
$70.6k
Exercised 14,000 options to buy
@ $5.04, valued at
$70.6k
|
|
| 01/19/2023 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 28,000 shares
@ $20.23, valued at
$566.4k
Sold 28,000 shares
@ $20.87, valued at
$584.4k
Sold 28,000 shares
@ $20.02, valued at
$560.6k
Exercised 28,000 options to buy
@ $5.04, valued at
$141.1k
Exercised 28,000 options to buy
@ $5.04, valued at
$141.1k
Exercised 28,000 options to buy
@ $5.04, valued at
$141.1k
Granted 701,680 options to buy
@ $20.45, valued at
$14.3M
|
|
| 10/13/2022 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 14,000 shares
@ $21.36, valued at
$299k
Sold 14,000 shares
@ $21.18, valued at
$296.5k
Sold 14,000 shares
@ $20.58, valued at
$288.1k
Exercised 14,000 options to buy
@ $4.12, valued at
$57.7k
Exercised 14,000 options to buy
@ $4.12, valued at
$57.7k
Exercised 14,000 options to buy
@ $4.12, valued at
$57.7k
|
|
| 09/15/2022 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 14,000 shares
@ $25.45, valued at
$356.3k
Sold 14,000 shares
@ $23.47, valued at
$328.6k
Sold 14,000 shares
@ $23.8, valued at
$333.2k
Exercised 14,000 options to buy
@ $4.12, valued at
$57.7k
Exercised 14,000 options to buy
@ $4.12, valued at
$57.7k
Exercised 14,000 options to buy
@ $4.12, valued at
$57.7k
|
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2022 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Sold 28,000 shares
@ $31.8, valued at
$890.4k
Sold 14,000 shares
@ $31.96, valued at
$447.4k
Sold 14,000 shares
@ $31.94, valued at
$447.2k
Sold 14,000 shares
@ $30.51, valued at
$427.1k
Exercised 28,000 options to buy
@ $4.12, valued at
$115.4k
Exercised 14,000 options to buy
@ $4.12, valued at
$57.7k
Exercised 14,000 options to buy
@ $5.04, valued at
$70.6k
Exercised 14,000 options to buy
@ $4.12, valued at
$57.7k
Exercised 14,000 options to buy
@ $5.04, valued at
$70.6k
|
|
| 01/31/2022 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 527,140 options to buy
@ $20.38, valued at
$10.7M
|
|
| 01/07/2022 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 658 shares
@ $26.1, valued at
$17.2k
|
|
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 753,804 options to buy
@ $5.22, valued at
$3.9M
|
|
| 07/21/2020 |
4
| Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $20, valued at
$500k
|
|
|
|